Cargando…
Inhibition of VEGFA Increases the Sensitivity of Ovarian Cancer Cells to Chemotherapy by Suppressing VEGFA-Mediated Autophagy
BACKGROUND: Ovarian cancer (OvCa) is the leading cause of death of gynecological malignancies worldwide. Vascular endothelial growth factor A (VEGFA), the most potent angiogenic factor, is responsible for tumor growth and angiogenesis, but its role in OvCa chemotherapy resistance remains unclear. ME...
Autores principales: | Li, Xia, Hu, Zhenhua, Shi, Huirong, Wang, Cong, Lei, Jia, Cheng, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443464/ https://www.ncbi.nlm.nih.gov/pubmed/32884298 http://dx.doi.org/10.2147/OTT.S250392 |
Ejemplares similares
-
TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis
por: Geng, Liying, et al.
Publicado: (2013) -
VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
por: Terme, Magali, et al.
Publicado: (2013) -
RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFA(xxx)b isoforms
por: Bridgett, Stephen, et al.
Publicado: (2017) -
Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition
por: Zhao, Wencao, et al.
Publicado: (2019) -
MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1
por: Yan, Jing-Jun, et al.
Publicado: (2015)